Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines
Details
Publication Year 2022-11-30,Volume 18,Issue #5,Page 2052701
Journal Title
Human Vaccines & Immunotherapeutics
Publication Type
Research article
Abstract
The Victorian Specialist Immunization Services (VicSIS) was established in Victoria, Australia, in February 2021, aiming to enhance vaccine safety services for Coronavirus disease (COVID-19) vaccines. VicSIS supports practitioners and patients with complex vaccine safety questions, including those who experience adverse events following immunization (AEFI) after COVID-19 vaccines. VicSIS provides individual vaccination recommendations, allergy testing, vaccine challenges, and vaccination under supervision. VicSIS initially comprised of eight adult COVID-19 specialist vaccination clinics, subsequently, expanding to better support pediatric patients as the Australian vaccine roll-out extended to adolescents and children. Since their establishment to September 2021, the inaugural VicSIS clinics received a total of 26,401 referrals and reviewed 6,079 patients. Consults were initially predominantly for pre-vaccination reviews, later predominantly becoming post-vaccination AEFI reviews as the program progressed. Regardless of the type of consult, the most common consult outcome was a recommendation for routine vaccination (73% and 55% of consult outcomes respectively). VicSIS is an integral component of the COVID-19 vaccination program and supports confidence in COVID-19 vaccine safety by providing consistent advice across the state. VicSIS aims to strengthen the health system through the pandemic, bolstering specialist immunization services beyond COVID-19 vaccines, including training the next generation of vaccinology experts.
Keywords
Adolescent; Adult; Adverse Drug Reaction Reporting Systems; *COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Child; Humans; Immunization/adverse effects; Population Surveillance; Vaccination/adverse effects; *Vaccines/adverse effects; Victoria; Covid-19; immunisation service; vaccination; vaccine allergy; vaccines
Department(s)
Infectious Diseases
PubMed ID
35471988
Open Access at Publisher's Site
https://doi.org/10.1080/21645515.2022.2052701
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-10-31 04:55:14
Last Modified: 2024-10-31 04:56:11

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙